liquid biopsy
145 articles
The Benefit of Being Your Own Advocate
Eric Borden decided to advocate for himself when a lesion was found on his pancreas. It was a good choice because it was pancreatic cancer.
BRCA Mutation Determines My Pancreatic Cancer Treatment
Chris Treubert started with one type of chemotherapy but when the results of genetic testing showed a BRCA mutation he changed treatment.
An Unexpected Diagnosis of PNET
Lisa Tayman was surprised to discover that the shoulder pain she had was from a pancreatic neuroendocrine tumor.
Vigilance Leads to Pancreatic Cancer Diagnosis
After his pancreatic cancer diagnosis, Michael Whalen searched for someone willing to treat him with chemotherapy.
Tomorrow Is a New Day
Abby Pezzulo was an active young working mother when she was diagnosed with a pancreatic neuroendocrine tumor.
A Second Opinion Saved My Life!
With encouragement from her husband, Janet McNabb went for a second opinion after a tumor was found on her pancreas.
Using the Lessons of Recovery in my Pancreatic Cancer Treatment
Robert Hessler used the lessons he learned as a recovering alcoholic to help him through the challenges of a Whipple procedure.
Pancreatitis and Pancreatic Cancer
When Wayne was diagnosed with pancreatitis, the tests showed a very high likelihood of pancreatic cancer.
Predicting Effective Therapy in Pancreatic Cancer
Dr. Kenneth Yu is leading a clinical trial that looks at a pancreatic cancer patient’s pharmacogenomic profile, to see which chemotherapy works better.
The Promise of Organoids
Dr. Brian Wolpin explains how organoids are being used to develop personalized treatment for pancreatic cancer patients.
Representing Genetic and Clinical Diversity in Pancreatic Cancer
Dr. Kentaro Sudo explores the possible causes for different responses to drugs among ethnic groups, pointing to the need for clinical diversity in trials.
New Trial to Find Biomarkers to Guide Treatment
Drs. Jennifer Knox and Elizabeth Jaffee lead the PASS-01 trial using biomarkers and other measures to choose individualized treatment.
Blood-Based Test Predicts What Drugs May Work Best
Dr. Kenneth Yu is testing a blood-based assay that looks at which types of chemotherapies will work best for each pancreatic cancer patient.
Urinary Tract Scans Lead to My Diagnosis
Ellen Robbins has the BRCA2 mutation, and that allowed her to participate in a clinical trial for her pancreatic cancer.
Being Persistent Led to my Cancer Diagnosis
Rod Devlin wasn’t getting an answer to his pain but he was persistent until he finally found a doctor that would give him a scan.